Cyclacel Pharmaceuticals Inc (NAS:CYCC)
$ 0.41 -0.039 (-8.69%) Market Cap: 882,000.00 Enterprise Value: -5.11 Mil PE Ratio: 0 PB Ratio: 0.74 GF Score: 26/100

Q4 2023 Cyclacel Pharmaceuticals Inc Earnings Call Transcript

Mar 19, 2024 / 08:30PM GMT
Release Date Price: $2.35 (-6.37%)
Operator

Good afternoon and welcome to the Fibrocell Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast.

At this time, all participants are in a listen only mode. After today's call, members of the financial community will have the opportunity to ask questions. If you would like to ask a question at that time, please press star one on your telephone keypad. If at any point your question has been answered, you may remove yourself from the queue by pressing star two and posing your question, we ask that you please pick up your handset to allow optimal sound quality. Lastly, if at any time during the call you should require operator assistance, please press star zero. Please note, today's call is being recorded. I would now like to turn the conference call over to the company. Please go ahead.

Grace Kim
Cyclacel Pharmaceuticals Inc - IR

Good afternoon, everyone, and thank you for joining today's conference call to discuss Cyclacel's financial results and business highlights for the fourth quarter and financial year ended

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot